Literature DB >> 3930115

Association of systemic light-chain deposition disease and amyloidosis: a report of three patients with renal involvement.

C Jacquot, J P Saint-Andre, G Touchard, D Nochy, C D'Auzac de Lamartinie, R Oriol, P Druet, J Bariety.   

Abstract

Three patients with renal involvement, plasma cell dyscrasia and systemic light chain deposition are reported in whom well characterized amyloid deposits were also found in the vessel walls. This association, not yet reported, is probably more frequent than believed and still brings nearer these two manifestations of monoclonal light chain deposition. Whether or not the finding of amyloid deposits during systemic light chain deposition is a separate entity and modifies the prognosis remains to be answered.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3930115

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  9 in total

1.  Light chain deposition disease neuropathy resembling amyloid neuropathy in a multiple myeloma patient.

Authors:  M P Grassi; F Clerici; C Perin; M Borella; A Gendarini; A Quattrini; R Nemni; A Mangoni
Journal:  Ital J Neurol Sci       Date:  1998-08

2.  Structure of a monoclonal kappa chain of the V kappa IV subgroup in the kidney and plasma cells in light chain deposition disease.

Authors:  M Cogné; J L Preud'homme; M Bauwens; G Touchard; P Aucouturier
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

3.  Amyloid associated muscle pseudohypertrophy: amelioration of motor dysfunction with plasmapheresis and dimethylsulphoxide.

Authors:  A Komiyama; M Kijima; M Takahashi; S Ishida; Y Ono
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-05       Impact factor: 10.154

4.  Systemic lambda light-chain deposition presenting with predominant cardiac involvement.

Authors:  M J Garton; S Walton; S W Ewen
Journal:  Postgrad Med J       Date:  1993-07       Impact factor: 2.401

5.  Light chain deposition disease of the liver without renal involvement in a patient with multiple myeloma related to liver failure and rapid fatal outcome.

Authors:  Spyros Michopoulos; Kalliopi Petraki; Constantina Petraki; Meletios-Athanasios Dimopoulos
Journal:  Dig Dis Sci       Date:  2002-04       Impact factor: 3.199

6.  Immunogold quantitation of immunoglobulin light chains in renal amyloidosis and kappa light chain nephropathy.

Authors:  M M Silver; S A Hearn; J C Walton; L A Lines; V M Walley
Journal:  Am J Pathol       Date:  1990-05       Impact factor: 4.307

7.  Light chain deposition disease of the kidney. Morphological aspects in 24 patients.

Authors:  E H Strøm; G B Fogazzi; G Banfi; C Pozzi; M J Mihatsch
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

8.  Immunoglobulin synthesis in primary and myeloma amyloidosis.

Authors:  J L Preud'homme; D Ganeval; J P Grünfeld; L Striker; J C Brouet
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

9.  Rapid deterioration of renal function in a patient with multiple myeloma associated with amyloid and light chain depositions.

Authors:  Naoko Nakayama; Yoshihide Fujigaki; Takayuki Tsuji; Masanori Sakakima; Hideo Yasuda; Akashi Togawa; Hiroyuki Suzuki; Tomoyuki Fujikura; Akihiko Kato; Satoshi Baba; Satoru Takahashi; Akira Hishida
Journal:  Clin Exp Nephrol       Date:  2009-12       Impact factor: 2.801

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.